drugset / Trial / NCT04462029
A Study to Compare the Pharmacokinetics of BR4002 and BR4002-1 in Healthy Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
This study is designed as a randomized, open-label, single-dose, 6x3 crossover study.
Timeline
- Start
- 2020-06-05
- Primary completion
- 2020-10-07
- Completion
- 2020-10-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BR4002 | Unknown | 5 mg | Other |
| Subject | BR4002-1 | Unknown | 5 mg | Oral |